Aura Biosciences Inc. (AURA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Aura Biosciences Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$6.40
+1.59% today
Market cap
$653M
Overall quality
44/100
Kronos AI 30-day
+7.6%
8 of 8 simulated paths end higher
Aura Biosciences Inc. (AURA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $653M. It trades at $6.40, up 1.59% today. Its overall quality score is 44 out of 100, ranked against the whole US market. 2 analysts' average target of $20.50 implies +220.3% from today's price. Kronos AI's 30-day forecast is +7.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $20.50 |
| Low – high | $18.00 – $23.00 |
| Analysts | 2 |
| Upside to average | +220.3% |
Kronos AI 30-day forecast
| Expected close | $6.78 (+7.6%) |
| Likely range | +3.3% … +16.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 40 |
| Solvency | 57 |
| Growth | 35 |
| Overall | 44 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.